Anti-Inflammatory Drug as a Treatment for Psychiatric Disorders
A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Medicinal Chemistry".
Deadline for manuscript submissions: closed (31 July 2022) | Viewed by 1882
Special Issue Editor
Interests: anti-inflammatory drugs; cytokines; glia cells; neuro-inflammation; pharmacology; prostaglandins; psychopharmacology; psychiatric disorders
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
In recent years, data have accumulated suggesting that inflammation may contribute to the pathophysiology of psychiatric disorders such as depression, bipolar disorder, and schizophrenia. Supporting findings include the following: (i) patients with psychiatric disorders were found to have increased levels of pro-inflammatory mediators in the plasma and in postmortem brain samples; (ii) psychotropic medications exhibited potent anti-inflammatory effects both in animal and human studies; and (iii) classic anti-inflammatory drugs such as corticosteroids and nonsteroidal anti-inflammatory drugs exerted beneficial effects in patients with psychiatric disorders.
This Special Issue will address the role of anti-inflammatory and anti-infectious drugs as a treatment for psychiatric disorders; original articles and review papers that address this topic are welcomed.
Dr. Abed N. Azab
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- anti-inflammatory drugs
- bipolar affective disorder
- corticosteroids
- COX inhibitors
- C-reactive protein
- cytokines
- depression
- efficacy
- minocycline
- immune disturbances
- inflammation
- mood disorders
- prostaglandins
- psychiatric illnesses
- schizophrenia
- side effects
